Prenatal diagnosis of genodermatoses: current scope and future capabilities

Authors


  • Conflict of interest: none

Sharon A. Glick, MD
SUNY Downstate Department of Dermatology
450 Clarkson Ave Box 46
Brooklyn
NY 11203
USA
E-mail: glicksharon@aol.com

Abstract

The genodermatoses encompass a range of inheritable skin diseases that may be associated with significant mortality and long-term morbidity. In the past, options for prenatal diagnosis of these diseases were limited to fetal skin biopsy. As a result of recent leaps made in genetics and molecular biology, DNA-based prenatal diagnosis is now available for an increasing number of genodermatoses, and newer non-invasive methods are being developed that have the potential for tremendous future impact in dermatology. Dermatologists caring for patients with genodermatoses should be aware of the options for screening and prenatal testing and partake in a multi-disciplinary approach to patient care.

Ancillary